Between April 26 and 27, the Regulatory Authorities of Medicines of Argentina (ANMAT), Brazil (ANVISA), Canada (Health Canada), Chile (ISP), Colombia (INVIMA), Cuba (CECMED), United States (USFDA) and Mexico (COFEPRIS) meet in the city of Santiago, Chile. To date, these are the authorities considered level IV in the Americas region.

On this occasion, a review will be made of the state of progress of the priority projects committed in the last NRAr meeting held in December 2017, in Washington DC, United States. In addition, the work agenda includes the review of the NRAr cooperation activities with other authorities in the region that does not have the same level of development, the review of the progress in the implementation of the Global Tool of the World Health Organization (WHO), and the presentation of topics of interest or concern to the NRAs, in order to identify future actions, in addition to preparing the Work Plan for the years 2018-2019.

The meeting may be accompanied by the link http://www.ispch.cl/reunionarn

Activity program

More information about the Annual Meeting in Chile available through the link http://www.ispch.cl/arns

System for Evaluation of the National Regulatory Authorities for Medicines

The Designation of Regional Reference Authority (NRAr) corresponds to the Regulatory Authorities that reach level IV of a rating system through evaluation based on indicators contained in the data collection tool, which is based on recommendations of the World Health Organization for the strengthening of Regulatory Bodies.

A level IV NRAr represents that the authority is competent and efficient in carrying out the regulatory functions recommended by PAHO / WHO to guarantee the efficacy, safety and quality of medicines.

One of its objectives is to support the Pan American Health Organization in strengthening activities of other national regulatory authorities in the Region.

More information about the System for Evaluation of the National Regulatory Authorities for Medicines is available here.